RHODE ISLAND HOSPITAL has received $1.6 million from the National Institutes of Health to study the effectiveness of providing medication and care to people with opioid use disorder at pharmacies. / COURTESY LIFESPAN CORP.
PROVIDENCE – Rhode Island Hospital has received $1.6 million from the National Institutes of Health to study the effectiveness of providing medication and care at pharmacies for people with opioid-use disorder, Lifespan Corp. announced Monday The three-year study will be conducted in collaboration with the University of Rhode Island College of Pharmacy, the R.I. Department…
Thanks for reading Providence Business News.
Create your free account or log in to continue reading.